Efficacy and safety of immune checkpoint inhibitors versus chemotherapy in the second-line treatment of advanced esophageal squamous cell carcinoma: a meta-analysis and systematic review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of immune checkpoint inhibitors versus chemotherapy in the second-line treatment of advanced esophageal squamous cell carcinoma: a meta-analysis and systematic review

Published:2023-03 Issue:3 Volume:15 Page:1186-1195
ISSN:2072-1439
Container-title:Journal of Thoracic Disease
language:
Short-container-title:J Thorac Dis

Author:

Zhu Kanghao,Chen Hui,Xu Congcong,Chen Dong,Jin Zixian,Ren Sijia,Witharana Pasan,Chen Baofu,Shen Jianfei

Publisher

AME Publishing Company

Subject

Pulmonary and Respiratory Medicine

Link

https://jtd.amegroups.com/article/download/73297/pdf

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilising systematic reviews to assess potential overtreatment and claim for better evidence-based research: an analysis of anticancer drugs versus supportive care in advanced esophageal cancer;Systematic Reviews;2024-07-18

2. Unleashing immunity against oral cancer with immune checkpoint inhibitors;Oral Oncology Reports;2024-06

3. Breaking Barriers: The Promise and Challenges of Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer;Biomedicines;2024-02-05

4. Efficacy and Safety of First-line Therapies for Advanced Unresectable Oesophageal Squamous Cell Cancer: a Systematic Review and Network Meta-analysis;Clinical Oncology;2024-01

5. Advancements in the research of immune checkpoint inhibitors for the treatment of advanced esophageal squamous cell carcinoma;American Journal of Cancer Research;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP